<DOC>
	<DOCNO>NCT02175303</DOCNO>
	<brief_summary>To evaluate safety efficacy use decidual stromal cell therapy toxicity inflammation , special focus allogeneic hematopoietic cell transplantation patient . The hypothesis test cell safe infuse anti-inflammatory healing effect .</brief_summary>
	<brief_title>A Pilot Study Using Placenta Derived Decidual Stromal Cells Toxicity Inflammation With Special Focus Allogeneic Hematopoietic Cell Transplantation Setting</brief_title>
	<detailed_description>Patients toxicity , inflammation hemorrhage receive decidual stromal cell approximately 1x10^6 cells/kg one occasion weekly interval dependent clinical response .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<criteria>Patients toxicity , inflammation hemorrhage .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>